Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search


Novogene provides NGS and bioinformatic services.

Novogene is a biotech company founded by Dr. Ruiqiang Li in 2011. It develops software for sequence mapping, variation detection, and genome assembly and has offices in Hong Kong, the United States and the United Kingdom.


Novogene is an Illumina Genome Network partner. They offer a range of NGS-based services for human, plant, animal and microbial DNA and RNA analysis.Services offered include human genome sequencing, gene regulation, single-cell sequencing, animal and plant solutions (such as genome sequencing), and microbial genome sequencing. Pharmaceutical companies can also utilize Novogene's technology for drug development related to insights gained from genomic sequencing. The technology at the company uses various systems, such as HiSeq X, to sequence genomes, which allows for the company to annually sequence 280,000 human genomes.


In its series B round of funding in 2016, Novogene raised $75 million.

Novogene, headquartered in Beijing with branches in Hong Kong, the U.S. and U.K., is a genomics solution provider with bioinformatics expertise and a large Illumina-based sequencing capacity in China.


November 2016
Novogene raises a $79,236,864 series B round from CMB International Capital Corporation, China Merchants Bank, SDIC Fund Management Company and Sigma Square Capital.
Novogene was founded by Ruiqiang Li.

Funding Rounds


Further Resources


Leading Edge Genomic Services & Solutions

March 28, 2019

New Products Posted to GenomeWeb: ChunLab, Streck, Novogene


August 9, 2019


June 11, 2021
Wolters Kluwer, a global leader in professional information, software solutions and services, announced today that Novogene has selected the CCH® Tagetik corporate performance management (CPM) expert solution to help the company digitize its management financial statements so it can achieve higher data accuracy and ensure reports are delivered in a timely manner., , , , Novogene is a leading provider of genomic services and solutions with cutting edge next-generation sequencing (NGS) and b...
Wolters Kluwer
June 11, 2021
/PRNewswire/ -- Wolters Kluwer, a global leader in professional information, software solutions and services, announced today that Novogene has selected the...
June 10, 2021
C2i Genomics, a cancer intelligence company, today announced it has signed a collaboration partnership agreement with NovogeneAIT Genomics, a leading global provider of genomic services and solutions. This partnership begins the global commercial launch of the C2-Intelligence Platform, a cancer diagnostics service that uses AI pattern recognition and whole-genome analysis to provide rapid and accurate detection of residual disease that is up to 100x more sensitive than competing technolo...
July 10, 2019
Mission Bio, the pioneer in targeted single-cell DNA analysis and precision genomics, today announced that it has launched sales in China through a distribution agreement with Novogene, a leading provider of genomic services and solutions globally. The deal brings the Mission Bio Tapestri® Platform to the rapidly expanding Chinese market. China is one of the world's largest next-generation sequencing (NGS) markets, with enormous opportunities for genomics. Thanks to greater investment i...


Golden logo
By using this site, you agree to our Terms & Conditions.